Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,746 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy.
Yamada R, Mizuno S, Uchida K, Yoneda M, Kanayama K, Inoue H, Murata Y, Kuriyama N, Kishiwada M, Usui M, Ii N, Tsuboi J, Tano S, Hamada Y, Tanaka K, Horiki N, Ogura T, Shiraishi T, Takei Y, Katayama N, Isaji S. Yamada R, et al. Among authors: murata y. Pancreas. 2016 May-Jun;45(5):761-71. doi: 10.1097/MPA.0000000000000597. Pancreas. 2016. PMID: 26784908 Free PMC article.
Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy.
Murata Y, Hamada T, Kishiwada M, Ohsawa I, Mizuno S, Usui M, Sakurai H, Tabata M, Ii N, Inoue H, Shiraishi T, Isaji S. Murata Y, et al. J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):413-25. doi: 10.1007/s00534-011-0440-3. J Hepatobiliary Pancreat Sci. 2012. PMID: 21898089
Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expression.
Kobayashi M, Mizuno S, Murata Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Ii N, Yamakado K, Inoue H, Shiraishi T, Yamada T, Isaji S. Kobayashi M, et al. Among authors: murata y. Pancreas. 2014 Apr;43(3):350-60. doi: 10.1097/MPA.0000000000000059. Pancreas. 2014. PMID: 24622063 Free PMC article.
Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus.
Okuda Y, Mizuno S, Shiraishi T, Murata Y, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamada T, Isaji S. Okuda Y, et al. Among authors: murata y. Biomed Res Int. 2014;2014:975380. doi: 10.1155/2014/975380. Epub 2014 Mar 13. Biomed Res Int. 2014. PMID: 24745029 Free PMC article. Clinical Trial.
Negative prognostic impact of renal replacement therapy in adult living-donor liver transplant recipients: preoperative recipient condition and donor factors.
Iwata H, Mizuno S, Ishikawa E, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Ito M, Isaji S. Iwata H, et al. Among authors: murata y. Transplant Proc. 2014 Apr;46(3):716-20. doi: 10.1016/j.transproceed.2013.11.113. Transplant Proc. 2014. PMID: 24767332
Biliary complications in 108 consecutive recipients with duct-to-duct biliary reconstruction in living-donor liver transplantation.
Mizuno S, Inoue H, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamada R, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Isaji S. Mizuno S, et al. Among authors: murata y. Transplant Proc. 2014 Apr;46(3):850-5. doi: 10.1016/j.transproceed.2013.11.035. Transplant Proc. 2014. PMID: 24767364
A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy.
Desaki R, Mizuno S, Tanemura A, Kishiwada M, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Tabata M, Isaji S. Desaki R, et al. Among authors: murata y. Biomed Res Int. 2014;2014:219038. doi: 10.1155/2014/219038. Epub 2014 Jun 12. Biomed Res Int. 2014. PMID: 25013768 Free PMC article.
2,746 results